{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:17:41Z","timestamp":1791778661646,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023174","name":"Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-01993-6","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:48:38Z","timestamp":1769748518000},"page":"1679-1694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induced Pluripotent Stem Cells (iPSCs) as a Regenerative Strategy for Parkinson\u2019s Disease: Opportunities and Challenges"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-8125","authenticated-orcid":false,"given":"Ahmad","family":"Faried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reno","family":"Rudiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmad","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djaja","family":"Rusmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizal","family":"Azis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sari Widya Kusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris Muhamad","family":"Nurjamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahyu","family":"Widowati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"1","key":"1993_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2017","unstructured":"Dorsey, E. R., & Bloem, B. R. (2017). The Parkinson Pandemic\u2014A call to action. JAMA Neurology, 75(1), 9. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurology"},{"key":"1993_CR2","doi-asserted-by":"publisher","unstructured":"Yang, W., Hamilton, J. L., Kopil, C., Beck, J. C., Tanner, C. M., Albin, R. L., Dorsey, E. R., Dahodwala, N., Cintina, I., Hogan, P., & Thompson, T. (2020). Current and projected future economic burden of Parkinson\u2019s disease in the U.S. Npj Parkinson S Disease, 6(1). https:\/\/doi.org\/10.1038\/s41531-020-0117-1","DOI":"10.1038\/s41531-020-0117-1"},{"key":"1993_CR3","doi-asserted-by":"publisher","unstructured":"Okun, M. S., Hickey, P. T., Machado, A. G., Kuncel, A. M., & Grill, W. M. (2022). Temporally optimized patterned stimulation (TOPS\u00ae) as a therapy to personalize deep brain stimulation treatment of Parkinson\u2019s disease. Frontiers in Human Neuroscience, 16. https:\/\/doi.org\/10.3389\/fnhum.2022.929509","DOI":"10.3389\/fnhum.2022.929509"},{"issue":"9996","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V., & Lang, A. E. (2015). Parkinson\u2019s disease. The Lancet, 386(9996), 896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"The Lancet"},{"issue":"1","key":"1993_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00441-017-2706-9","volume":"373","author":"MG Spillantini","year":"2017","unstructured":"Spillantini, M. G., & Goedert, M. (2017). Neurodegeneration and the ordered assembly of \u03b1-synuclein. Cell and Tissue Research, 373(1), 137\u2013148. https:\/\/doi.org\/10.1007\/s00441-017-2706-9","journal-title":"Cell and Tissue Research"},{"issue":"4","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","volume":"483","author":"DJ Surmeier","year":"2016","unstructured":"Surmeier, D. J., Schumacker, P. T., Guzman, J. D., Ilijic, E., Yang, B., & Zampese, E. (2016). Calcium and parkinson\u2019s disease. Biochemical and Biophysical Research Communications, 483(4), 1013\u20131019. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.168","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"24","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1039\/d3ma00623a","volume":"4","author":"T Oz","year":"2023","unstructured":"Oz, T., Kaushik, A. K., & Kujawska, M. (2023). Advances in graphene-based nanoplatforms and their application in parkinson\u2019s disease. Materials Advances, 4(24), 6464\u20136477. https:\/\/doi.org\/10.1039\/d3ma00623a","journal-title":"Materials Advances"},{"issue":"16","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly, B. S., & Lang, A. E. (2014). Pharmacological treatment of Parkinson disease. Journal of the American Medical Association, 311(16), 1670. https:\/\/doi.org\/10.1001\/jama.2014.3654","journal-title":"Journal of the American Medical Association"},{"key":"1993_CR9","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","volume":"22","author":"A Sauerbier","year":"2015","unstructured":"Sauerbier, A., Jenner, P., Todorova, A., & Chaudhuri, K. R. (2015). Non motor subtypes and parkinson\u2019s disease. Parkinsonism & Related Disorders, 22, S41\u2013S46. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.027","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"1993_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"issue":"5","key":"1993_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"issue":"2","key":"1993_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12015-010-9138-1","volume":"6","author":"D Kim","year":"2010","unstructured":"Kim, D., Lee, J. S., Leem, J. W., Huh, Y. J., Kim, J. Y., Kim, H., Park, I., Daley, G. Q., Hwang, D., & Kim, D. (2010). Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Reviews and Reports, 6(2), 270\u2013281. https:\/\/doi.org\/10.1007\/s12015-010-9138-1","journal-title":"Stem Cell Reviews and Reports"},{"issue":"7151","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313\u2013317. https:\/\/doi.org\/10.1038\/nature05934","journal-title":"Nature"},{"issue":"5858","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science"},{"issue":"3","key":"1993_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., Davis, M. M., Lanier, L. L., & Schrepfer, S. (2019). Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nature Biotechnology, 37(3), 252\u2013258. https:\/\/doi.org\/10.1038\/s41587-019-0016-3","journal-title":"Nature Biotechnology"},{"key":"1993_CR16","doi-asserted-by":"publisher","unstructured":"Xu, J., Yu, L., Guo, J., Xiang, J., Zheng, Z., Gao, D., Shi, B., Hao, H., Jiao, D., Zhong, L., Wang, Y., Wu, J., Wei, H., & Han, J. (2019). Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system. Stem Cell Research & Therapy, 10(1). https:\/\/doi.org\/10.1186\/s13287-019-1303-0","DOI":"10.1186\/s13287-019-1303-0"},{"key":"1993_CR17","doi-asserted-by":"publisher","unstructured":"Tang, S. Y., Zha, S., Du, Z., Zeng, J., Zhu, D., Luo, Y., & Wang, S. (2021). Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells. Stem Cell Research & Therapy, 12(1). https:\/\/doi.org\/10.1186\/s13287-021-02648-4","DOI":"10.1186\/s13287-021-02648-4"},{"issue":"3","key":"1993_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009). Highly efficient neural conversion of human ES and iPS cells by dual Inhibition of SMAD signaling. Nature Biotechnology, 27(3), 275\u2013280. https:\/\/doi.org\/10.1038\/nbt.1529","journal-title":"Nature Biotechnology"},{"issue":"7378","key":"1993_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., Yang, L., Beal, M. F., Surmeier, D. J., Kordower, J. H., Tabar, V., & Studer, L. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of parkinson\u2019s disease. Nature, 480(7378), 547\u2013551. https:\/\/doi.org\/10.1038\/nature10648","journal-title":"Nature"},{"issue":"2","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo, J., Xiao, Y., Sun, A. X., Cukuroglu, E., Tran, H., G\u00f6ke, J., Tan, Z. Y., Saw, T. Y., Tan, C., Lokman, H., Lee, Y., Kim, D., Ko, H. S., Kim, S., Park, J. H., Cho, N., Hyde, T. M., Kleinman, J. E., Shin, J. H., & Ng, H. (2016). Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and Neuromelanin-Producing neurons. Cell Stem Cell, 19(2), 248\u2013257. https:\/\/doi.org\/10.1016\/j.stem.2016.07.005","journal-title":"Cell Stem Cell"},{"issue":"9","key":"1993_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jnr.24014","volume":"95","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi, T., Morizane, A., Doi, D., Okita, K., Nakagawa, M., Yamakado, H., Inoue, H., Takahashi, R., & Takahashi, J. (2017). Idiopathic parkinson\u2019s disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains. Journal of Neuroscience Research, 95(9), 1829\u20131837. https:\/\/doi.org\/10.1002\/jnr.24014","journal-title":"Journal of Neuroscience Research"},{"issue":"6","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan, S. D., Dolatabadi, N., Chan, S. F., Zhang, X., Akhtar, M. W., Parker, J., Soldner, F., Sunico, C. R., Nagar, S., Talantova, M., Lee, B., Lopez, K., Nutter, A., Shan, B., Molokanova, E., Zhang, Y., Han, X., Nakamura, T., Masliah, E., & Lipton, S. A. (2013). Isogenic human IPSC parkinson\u2019s model shows nitrosative Stress-Induced dysfunction in MEF2-PGC1\u0391 transcription. Cell, 155(6), 1351\u20131364. https:\/\/doi.org\/10.1016\/j.cell.2013.11.009","journal-title":"Cell"},{"issue":"6","key":"1993_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.stemcr.2015.11.004","volume":"5","author":"AJ Schwab","year":"2015","unstructured":"Schwab, A. J., & Ebert, A. D. (2015). Neurite aggregation and calcium dysfunction in iPSC-Derived sensory neurons with parkinson\u2019s Disease-Related LRRK2 G2019S mutation. Stem Cell Reports, 5(6), 1039\u20131052. https:\/\/doi.org\/10.1016\/j.stemcr.2015.11.004","journal-title":"Stem Cell Reports"},{"key":"1993_CR24","doi-asserted-by":"publisher","unstructured":"Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., Hargus, G., Deleidi, M., Lawson, T., Bogetofte, H., Perez-Torres, E., Clark, L., Moskowitz, C., Mazzulli, J., Chen, L., & Isacson, O. (2012). Pharmacological rescue of mitochondrial deficits in iPSC-Derived neural cells from patients with Familial parkinson\u2019s disease. Science Translational Medicine, 4(141). https:\/\/doi.org\/10.1126\/scitranslmed.3003985","DOI":"10.1126\/scitranslmed.3003985"},{"issue":"7230","key":"1993_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/457675a","volume":"457","author":"NJ Allen","year":"2009","unstructured":"Allen, N. J., & Barres, B. A. (2009). Glia \u2014 more than just brain glue. Nature, 457(7230), 675\u2013677. https:\/\/doi.org\/10.1038\/457675a","journal-title":"Nature"},{"issue":"3","key":"1993_CR26","doi-asserted-by":"publisher","first-page":"108642","DOI":"10.1016\/j.celrep.2020.108642","volume":"34","author":"C Philippot","year":"2021","unstructured":"Philippot, C., Griemsmann, S., Jabs, R., Seifert, G., Kettenmann, H., & Steinh\u00e4user, C. (2021). Astrocytes and oligodendrocytes in the thalamus jointly maintain synaptic activity by supplying metabolites. Cell Reports, 34(3), 108642. https:\/\/doi.org\/10.1016\/j.celrep.2020.108642","journal-title":"Cell Reports"},{"issue":"5","key":"1993_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., Shibata, T., Kunisada, T., Takahashi, M., Takahashi, J., Saji, H., & Yamanaka, S. (2011). A more efficient method to generate integration-free human iPS cells. Nature Methods, 8(5), 409\u2013412. https:\/\/doi.org\/10.1038\/nmeth.1591","journal-title":"Nature Methods"},{"key":"1993_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"J Takahashi","year":"2020","unstructured":"Takahashi, J. (2020). iPS cell-based therapy for parkinson\u2019s disease: A Kyoto trial. Regenerative Therapy, 13, 18\u201322. https:\/\/doi.org\/10.1016\/j.reth.2020.06.002","journal-title":"Regenerative Therapy"},{"issue":"5","key":"1993_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D., & Jaenisch, R. (2016). Induced pluripotent stem cells Meet genome editing. Cell Stem Cell, 18(5), 573\u2013586. https:\/\/doi.org\/10.1016\/j.stem.2016.04.013","journal-title":"Cell Stem Cell"},{"issue":"10","key":"1993_CR30","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A., & Knoblich, J. A. (2014). Generation of cerebral organoids from human pluripotent stem cells. Nature Protocols, 9(10), 2329\u20132340. https:\/\/doi.org\/10.1038\/nprot.2014.158","journal-title":"Nature Protocols"},{"key":"1993_CR31","doi-asserted-by":"publisher","unstructured":"Arenas, E., Salt\u00f3, C., & Villaescusa, C. (2015). WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for parkinson\u2019s disease. SpringerPlus, 4(S1). https:\/\/doi.org\/10.1186\/2193-1801-4-s1-l49","DOI":"10.1186\/2193-1801-4-s1-l49"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-01993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-01993-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-01993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:21:26Z","timestamp":1780482086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-01993-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-01993-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflicts of Interest"}}]}}